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Abstract
Background Leishmaniasis is a serious public health problem in Yemen.
Objectives This study was designed to identify clinical and epidemiological features of
leishmaniasis in Yemen.
Methods The study was conducted at the Regional Leishmaniasis Control Center in
central Yemen. Data sourced from the medical records of 152 patients with confirmed
active leishmaniasis, managed during April–August 2013, were analyzed.
Results A total of 94.1% of patients were rural residents. Al Bayda was the most endemic
governorate (59.9%). Children represented the group at highest risk (57.2%), followed by
adult females (32.9%); together these groups accounted for 90.1% of all patients.
Mucocutaneous leishmaniasis was the most prevalent form (49.3%), followed by cutaneous
leishmaniasis (47.4%), and visceral leishmaniasis (3.3%). The wet ulcer was the most
common type of lesion (49.7%) and the single lesion (69.4%) represented the most
common presentation. All patients were ignorant of the nature of the disease, and 55.9%
had a history of using “popular” treatments.
Conclusions Cutaneous, mucocutaneous, and visceral leishmaniases have significant
endemicity in Yemen, especially in central areas. Al Bayda is the governorate with the
highest endemicity, and rural children and women represent the populations at highest risk.
Mucocutaneous leishmaniasis seems to be the most prevalent form and a single wet ulcer
is the most common presentation. Infected refugees may represent new foci for imported
Leishmania species. Ecology, geography, climate change, cultural gender- and age-specific
duties, urban night activities, and use of popular treatments are among proven risk factors.
Introduction
Leishmaniasis, a parasitic vector-borne disease caused by
obligate intra-macrophage protozoa, is endemic in large
areas of the tropics, subtropics, and the Mediterranean
basin. It is caused by more than 20 Leishmania species
and is transmitted to humans by sandflies.1 Approxi-
mately, 600 species of sandfly are known, but only 10%
of these act as disease vectors.2 Infection by human pro-
tozoan parasites of the genus Leishmania can lead,
depending primarily on Leishmania species, to cutaneous
leishmaniasis (CL) or mucocutaneous leishmaniasis
(MCL) lesions, or to fatal generalized visceral leishmania-
sis (VL) infection.3
Leishmania was first identified in 1885 by Cunningham
in India in a subject from Kala-azar. Donovani, Leish-
man, and Marchand confirmed its existence in 1903 with
the discovery of this protozoan in a subject who died of
kala-azar in Germany. World Health Organization
(WHO) epidemiological data estimate that currently more
than 12 million people suffer from leishmaniasis and that,
in an at-risk population of about 350 million people,
1.5–2 million new cases will develop per year, of which
1–1.5 million cases will represent CL and 500,000 cases
will represent VL.4
Although it is estimated to cause the ninth largest bur-
den among individual infectious diseases, leishmaniasis is
largely ignored in discussions of tropical disease priori-
ties.5,6 This consignment of the disease to critical oblivion
results from its complex epidemiology and ecology, the
lack of simple, easily applied tools for case management,
and the paucity of current incidence data, and often
results in a failure on the part of policymakers to recog-
nize its importance.7,8
Climate change affects the distribution of leishmaniasis
in three ways: (i) through the effects of temperature on
parasite development and vector competence; (ii) through
the effects of temperature and other environmental vari-
ables on the range and abundance of the sandfly species
that act as vectors; and (iii) through socioeconomic
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changes that affect the amount of human contact with
transmission cycles.9
The burden of leishmaniasis falls disproportionately on
the poorest segments of the global population. Within
endemic areas, increased infection risk is mediated
through poor housing conditions and inadequate environ-
mental sanitation, lack of personal protective measures,
and economically driven migration and employment that
bring non-immune hosts into contact with infected sand-
flies.7
The Republic of Yemen is a developing country with
very poor healthcare conditions. Medical facilities and
qualified personnel are limited, and the population, espe-
cially women and children, suffer from deficiencies in
medical care.10
Leishmaniasis is a public health problem in Yemen,
where it has a nationwide distribution.11 A full epidemio-
logical study of skin diseases from Yemen is not avail-
able, although some data have been published from
nearby Arab countries.12 However, although the disease
is not well documented, it seems to be endemic in the
country and is primarily widespread in arid and semi-arid
areas.10
Sarnelli13 reported five cases of MCL in Sanaa as early
as 1933. Cutaneous leishmaniasis is widespread in
Yemen, and its true incidence is not well reflected as only
a few published documents are available.14 The cutaneous
form is caused by Leishmania tropica (anthroponotic CL
[ACL]) and Leishmania major (zoonotic CL [ZCL]).15
Further, VL (kala-azar) is endemic in Yemen. This
diagnosis is generally missed or delayed for months or
years, and some patients are treated blindly.16 Kala-azar
was first reported in the northern part of Yemen over a
century ago, but sporadic cases of the disease are now
widely reported from all over the country.17 Nearly 4047
cases of VL, mostly in young children, were reported by
the Ministry of Health in the decade to 1988.18
The scanty information on VL epidemiology in Yemen
shows that the causative organisms are species of the
Leishmania donovani complex (anthroponotic VL [AVL])
and Leishmania infantum complex (zoonotic VL [ZVL]),
and vectors are Phlebotomus orientalis and Phlebotomus
arbicus.
Canine leishmaniasis was reported by Rioux et al.19
from a human VL focus in the Taiz area of Yemen.
The present study was conducted to identify the clinical
and epidemiological features of leishmaniasis disease in
Yemen, particularly in the central areas of the country.
Materials and methods
This study was conducted at the Regional Leishmaniasis
Control Center (RLCC), Yemen, through a retrospective review
of the medical records of patients with confirmed leishmaniasis
from three governorates in central Yemen, all of whom were
managed during the 5 months of the study period (April–August
2013).
The study area (Fig. 1) involved Al Bayda (Al-Baida), Ibb,
and Dhamar governorates. These areas typically reflect the
morphology and landscape of the central (inner) highlands,
which represent a plateau of 2000–3200 m a.s.l.20
The study involved all leishmaniasis patients registered at the
RLCC and living in the study area, of both sexes and all age
groups. Study subjects were required to have been diagnosed
and managed during the study period at the RLCC offices or to
have been actively detected and managed during remote field
campaigns and to show active leishmaniasis lesion(s) or
symptoms. All patients were required to have been given a
clinical diagnosis of leishmaniasis, which had been confirmed in
laboratory tests by cytology, histopathology, or immunology
(enzyme-linked immunosorbent assay [ELISA]), and to have
filled out the surveillance questionnaire.
The study sample was obtained by screening all patient
records. Any patient who had been living outside the study
area, had not been clinically and laboratory test-diagnosed with
leishmaniasis, did not have active leishmaniasis lesion(s), had
not completed the questionnaire, or had not been managed by
the center’s staff was excluded from this study.
A total of 152 valid records were found to be compliant with
the study’s inclusion and exclusion criteria, and thus those 152
confirmed leishmaniasis patients were considered as the study
population.
In this study, individuals aged ≤17 years were classified as
children. The differentiation between CL and MCL was based
on clinical findings; lesions that involved mucous membranes of
the eyelids, nose, or mouth with any degree of inflammation
were considered to represent MCL.21
During RLCC field visits, center staff had walked around
villages and looked for any possible risk factors. Surveillance
visits covered disadvantaged areas that included refugee
camps and marginalized camps in eight districts. Geographic
Figure 1 Map of Yemen showing the three governorates in
the study area
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and ecological surveillance data were also considered in this
study.
Study variables included age, sex, clinical form, number and
nature of lesion(s), distribution, residence, and awareness
status.
Results
Data analysis of the selected records showed that the
majority of patients were Yemenis (59.9% of them were
Al Bayda inhabitants), and two were Ethiopian refugees.
Most patients lived in rural areas. Age at presentation
ranged from 2 months to 120 years. The delay before
first presentation ranged from 2 weeks to 16 months.
Four families in which all members were infected were
identified (Fig. 2). Four patients reported a history of vis-
its to other endemic districts in the governorates of Ray-
mah, Hudeidah, and Taiz in the west and south of the
country.
Overall, the prevalence of leishmaniasis was higher
among children than adults, higher among male than
female children, and higher among female than male
adults. Children and women accounted for 90.1% of
identified cases (n = 137 patients) (Table 1, Fig. 3).
Mucocutaneous disease was the most prevalent form of
leishmaniasis (49.3%). Children were more affected than
adults by all forms of the disease (Table 2, Fig. 4).
All VL patients were children. Principal presentations
included high intermittent fever, marked loss of weight,
abdominal distension, malaise, and xerosis.
Most patients (69.4%) presented with a single lesion
on an exposed part of the body; two patients had lesions
on the abdomen and back. The wet form was the most
common clinical presentation (49.7%).
A total of 128 patients were treated successfully using
available topical and systemic regimens. Treatment in
these patients achieved no or minimal scarring, except in
Figure 2 Diffuse nodulo-ulcerative lesions of cutaneous
leishmaniasis infecting a mother and both her children
Table 1 Characteristics of patients with leishmaniasis
(n = 152) in central Yemen
Variable Group n Percentage
Sex Male 85 55.9
Female 67 44.1






Clinical form CL 72 47.4
MCL 75 49.3
VL 5 3.3









Site of presentation (CL and
MCL)
Exposed areas 144 98.0
Hidden areas 3 2.0
Residence Rural 143 94.1
Urban/suburban 9 5.9
Geographic distribution Al Bayda
governorate
91 59.9




CL, cutaneous leishmaniasis; MCL, mucocutaneous leish-




























Figure 3 Overall prevalences of leishmaniasis by sex and age
group
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four patients with late presentations who developed nasal
deformity (three adult women) and nasal perforation (one
female child) (Fig. 5). Of the remaining patients, five were
referred for further management, and 19 were lost from
follow-up. The most commonly used treatment comprised
pentavalent antimonial-containing compounds.
Most patients presented at later than 4 months after
disease onset. Some late patients presented with advanced
symptoms such as huge ulcers, dissemination, diffuse
facial erythema (Fig. 6), mucosal involvement, and muti-
lation.
Eighty-five patients (55.9%) had tried popular forms of
treatment before their first presentation, and some of
these had developed unnecessary complications. Sub-
stances such as animal saliva (e.g. chameleon), herbal
(e.g. cactus) recipes, corrosive chemicals, and topical ste-
roids had been used.
The majority of patients belonged to farming families
living in remote villages and working in agriculture. Com-
mon practices included keeping livestock within 100 m of
human habitations and sleeping on the ground. Most
patients did not adhere to proper hygiene practices.
Constant growth in populations of dogs, cats, and
rodents was reported. All patients displayed a lack of
essential knowledge about the nature of the disease, its
etiology, vectors, and reservoirs, and primary protective
measures; some of them described the disease as attribut-
able to air or water pollution. Badah, Ofiah, and Atharah
were identified as local synonyms for leishmaniasis in the
study areas. All of these terms mean stigma and refer to
both esthetic and social stigmatization.
During field campaigns, RLCC staff noticed that tribal
and rural populations prefer to live in houses that are
close together, which lie in unplanned slums or settle-
ments, near to uncovered water sources, and often lack
adequate water supplies and sanitation facilities. In vil-
lages (particularly around Radaa), children and young
adults were seen working in khat (a stimulant plant
which accounts for about 50% of the gross domestic
product of the agricultural sector in Yemen22) cultivation.
Hundreds of African refugees were seen working in these
farms, and sandflies were also seen in many locations,
especially in domestic animal shelters and mud houses.
Discussion
There are no solid data on the incidence of Leishmania
infections in Yemen, but the disease is certainly under-
reported, especially in women and children, and may
exceed 10,000 cases per year.10
From the current study, CL, MCL, and VL seem to be
endemic in central Yemen, and Al Bayda governorate
seems to be the area with the highest endemicity. Other
reports from Yemen have described the occurrence of CL
Table 2 Prevalences of different forms of leishmaniasis by
age group (n = 152)
Age group
CL MCL VL
n (%) n (%) n (%)
Children 42 (27.6) 40 (26.3) 5 (3.3)
Adults 30 (19.7) 35 (23.0) 0
CL, cutaneous leishmaniasis; MCL, mucocutaneous leish-















Clinical form of leishmaniasis
Children
Adults
Figure 4 Prevalences of different clinical forms of
leishmaniasis by age group
Figure 5 Destructive mucocutaneous leishmaniasis ulcer
complicated by nasal perforation in a female child
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in Hajjah, Amran, Sadah, Sanaa, Al-Hudeidah, Taiz, Ibb,
Mahweet, Raimah, and Al-Jouf governorates in northern,
western, and southern Yemen, of both zoonotic and an-
throponotic types, and caused mainly by L. tropica and
L. major.10,15,19,23–25 Others that cited the endemicity of
VL reported most cases as registered in southeast and
northern Yemen and as caused mainly by L. infantum
and L. donovani.19,24
Overall, the prevalence of leishmaniasis was higher
among children than adults and was markedly higher in
male than in female children and in female than in male
adults; a comparable situation was reported from Afghan-
istan.26 Children and women can be considered as one
comparator group as they represent the sector suffering
from the greatest deficiencies of medical care in Yemen.10
It is useful to compare incidences of leishmaniasis in
Yemen with those in Afghanistan because these countries
have comparable geographic and socioeconomic features;
similar comparisons have been made with reference to
malaria.27
It has been speculated that much of the observed excess
risk in male children and adult females may derive from
habitual gender- and age-specific occupational roles: most
boys and women work in agriculture and animal care,
and are responsible for procuring water, especially at
dusk and in the early morning, which increases their
exposure to sandfly bites. In addition, male children
(57.4% of working children in Yemen are agricultural
workers28) often spend several hours of the night guard-
ing khat farms.
In the present study, VL was found to affect mainly
children; similar findings were reported from southern
Yemen by Hamid and Gobah.29
The current study shows that MCL was the most pre-
dominant form, a finding that may be unique to the cen-
tral areas of the country and which represents a matter of
serious concern; no similar situation has been previously
addressed in Yemen.
The prevalence of CL was higher among children than
adults; similar data were reported by Ullah et al. from
Pakistan.30 There are no comparable reports from other
regions of Yemen.
The majority of patients presented with single lesions.
Comparable findings were obtained by Khatri et al. in
northern Yemen, who also described most patients as
being from rural areas.25 Single lesions are usually
detected in L. tropica infection.31,32
Multiple lesions are seen in L. major infection.33,34 In
the Old World, this form is caused by Leishmania ethio-
pica.33 In the current study, the presence of multiple
Figure 6 Diffuse form of leishmaniasis
in a 120-year-old woman
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lesions in 30.6% of patients may indicate the endemicity
of these species in the study areas.
Dissemination in CL may derive from a lack of cell-
mediated immunity to Leishmania antigen, which then
results in the uncontrolled growth of the parasite.34 This
may have relevance to the current study population.
The wet form was the most common clinical presenta-
tion; comparable findings were reported from Iraq by Al-
Mafraji et al.35
Based on the findings of the current study, refugees
infected with disseminated CL or MCL may represent
new foci for imported Leishmania species; refugees living
in Yemen are predominantly from endemic countries such
as Iraq, Somalia, Ethiopia,36 and Syria.37
Leishmania species, vectors, and reservoirs in central
Yemen have not been studied. However, the relative simi-
larity between the spectrum of clinical presentations
found in this study and those described in other reports
from Yemen and comparable countries may imply the
presence of the same strains; specifically, L. major may
be the most prevalent strain in central Yemen.
Inherited habits, poverty, and a perceived inability to
obtain a proper diagnosis and treatment were among the
risk factors identified in this study. The last of these may
encourage patients to use hazardous methods of popular
treatment; the WHO has reported that 75% of rural pop-
ulations in Yemen do not have easy access to local health
services.38
Findings in the current study indicate that the inci-
dence of leishmaniasis infection peaks in August
(autumn). In the semi-arid highlands that comprise the
area covered by the present study, mean temperatures
range from <15 °C in winter to 25 °C in summer, and
rainfall is heavier in autumn.20 The rate of warming is
projected to be more rapid in these areas than in areas
closer to the coast, which is consistent with the higher
rates of warming projected for the Arabian peninsula
and East Africa.20 In 2011, the Global Facility for
Disaster Reduction and Recovery (GFDRR) reported
that Yemen is highly vulnerable to the adverse impacts
of climate change.39
Conclusions
Many risk factors have been proven to increase the dis-
ease burden imposed by leishmaniasis and the overall risk
to the public in Yemen. Ecology, geography, climate
change, cultural gender- and age-specific duties, urban
night activities, popular treatment methods, illiteracy,
overcrowding, the practice of keeping domestic animals
indoors, constant increases in rodent and dog popula-
tions, and improper diagnosis, treatment, housing,
hygiene, and sanitation are among these factors.
This study is expected to aid the RLCC and health
authorities in estimating incidences of infection and iden-
tifying major risk factors that can be used to inform the
development and implementation of initiatives to raise
awareness and knowledge of leishmaniasis and to support
early diagnosis and control strategies.
Recommendations
Yemen is often missed out of maps of the worldwide dis-
tribution of leishmaniasis. These maps should be redrawn
regularly and should consider Yemen as one of the most
endemic countries.
Because CL can develop to MCL, especially in poor and
immunocompromised individuals, I would like to suggest
that leishmaniasis disease should be reclassified as consist-
ing of only two major clinical entities, CL and VL, and that
all other forms should be considered as complications.
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